geneprint

Whole Genome Seq

What is Whole Genome Sequencing (WGS)?

Whole Genome Sequencing (WGS) is the most comprehensive method for analyzing an individual’s complete DNA sequence. It decodes 100% of the genome, including coding (exons), non-coding (introns, promoters, enhancers), repetitive regions, and regulatory elements, enabling a full view of genetic variation.

WGS captures single nucleotide variants (SNVs), insertions/deletions (indels), copy number variations (CNVs), structural variants (SVs), and even mitochondrial DNA mutations — making it a powerful tool for both clinical diagnostics and research discovery.

Overview

  • Purpose: Decode the entire genome to identify all types of genetic variation

  • Target Area: Entire nuclear and mitochondrial genome (~3.2 billion base pairs)

  • Applications: Rare disease diagnosis, cancer genomics, population genetics, infectious disease tracking, pharmacogenomics

  • Output: High-resolution map of all known and novel genomic variants

How WGS Works

  1. Sample Collection & DNA Extraction
    Genomic DNA is extracted from biological samples like blood, saliva, or tissue.

  2. Library Preparation
    DNA is fragmented and sequencing adapters are ligated to both ends.

  3. Sequencing
    Libraries are sequenced using high-throughput platforms such as Illumina, MGI, Oxford Nanopore (ONT), or PacBio.

  4. Data Processing & Alignment
    Raw reads are aligned to a reference genome (e.g., GRCh38) using tools like BWA or Minimap2.

  5. Variant Calling & Annotation
    Software pipelines detect SNPs, indels, CNVs, and structural variants. These are annotated using databases such as ClinVar, gnomAD, OMIM, etc.

Applications of Whole Genome Sequencing

  • Rare Disease Diagnosis
    Detects causative variants even outside coding regions when other methods fail.

  • Cancer Genomics
    Identifies somatic mutations, structural rearrangements, and tumor mutational burden.

  • Prenatal & Neonatal Screening
    Non-invasive or early detection of genetic abnormalities.

  • Infectious Disease Genomics
    Tracks viral evolution (e.g., SARS-CoV-2), antimicrobial resistance, or pathogen outbreaks.

  • Population & Evolutionary Genomics
    Studies human variation, ancestry, and natural selection patterns.

  • Pharmacogenomics
    Evaluates how genes affect drug response and metabolism.

  • Gene Discovery & Functional Genomics
    Links phenotype to genotype across regulatory and structural regions.

Advantages of WGS

  • Complete Coverage
    Captures coding, non-coding, regulatory, and repetitive DNA.

  • High Resolution
    Detects rare, common, and novel variants with base-pair accuracy.

  • Unbiased
    Does not rely on gene panels or capture probes; ideal for discovering unknown variants.

  • Structural Variation Detection
    Identifies large deletions, duplications, inversions, and translocations.

  • Mitochondrial Sequencing
    Captures both nuclear and mitochondrial genomes in one workflow.

  • Future-Proof
    Once sequenced, the data can be reanalyzed as new knowledge or tools emerge.

Key Features of WGS

FeatureDescription
CoverageTypically 30× for germline, 100×+ for somatic/cancer WGS
Genome Size~3.2 billion base pairs (human genome)
Read TypesShort-read (Illumina), Long-read (PacBio, ONT)
Variant Types DetectedSNPs, indels, CNVs, SVs, tandem repeats, mitochondrial variants
Turnaround Time2–8 weeks depending on pipeline and platform
Data Size90–150 GB per genome (FASTQ), compressed BAM/VCF available

Limitations and Challenges

  • Cost
    Though decreasing, WGS is more expensive than targeted methods.

  • Data Analysis Complexity
    Requires high computational power and expert bioinformatics.

  • Variant Interpretation
    Many variants are of uncertain significance, especially in non-coding regions.

  • Incidental Findings
    May reveal unexpected or unrelated genetic information (e.g., predisposition to disease).

  • Ethical and Privacy Concerns
    WGS data is sensitive and must be stored and handled with strict confidentiality.